CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Institut National De La Sant Et De La Recherche Mdicale Inserm's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Apr 3, 2024Aav-Mediated Gene Therapy Restoring The Otoferlin Gene4
Nov 23, 2022Method For Treating Checkpoint Inhibitors Induced Adverse Events1
Oct 6, 2021Il-15 And Il-15Raplha Sushi Domain Based Modulokines2
Dec 9, 2020Recombinant Adeno-Associated Virus Particle Purification With Multiple-Step Anion Exchange Chromatography1
Nov 18, 2020Methods For Producing A Population Of Pancreatic Beta-Cells1
Mar 11, 2020Methods And Pharmaceutical Compositions For The Treatment Of Age-Related Macular Degeneration (Amd)1
Jul 11, 2018Il-15 And Il-15Raplha Sushi Domain Based Modulokines1